Aprepitant 40 mg Prescription Drug Recalled for Manufacturing Temperature Deviations
McKesson Medical-Surgical is recalling 29 boxes of Aprepitant 40 mg capsules nationwide due to temperature abuse during manufacturing that violated current Good Manufacturing Practice standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing process deviations without reported illnesses or injuries. Temperature abuse affecting drug stability is a quality issue rather than a direct safety hazard.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling 29 boxes of Aprepitant 40 mg capsules distributed nationwide. The recall was initiated due to manufacturing process deviations identified as temperature abuse that did not conform to current Good Manufacturing Practice (cGMP) standards.
Aprepitant is a prescription medication used to prevent nausea and vomiting. The temperature abuse during manufacturing may have affected the drug's stability. No illnesses or injuries have been reported associated with this recall.
Consumers should contact their pharmacy or healthcare provider if they have this product. Patients should not stop taking their medication without consulting their doctor.
The recalled product
- Product
- APREPITANT (APREPITANT)
- Brand
- APREPITANT
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Affected units
- 29
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same brand · APREPITANT
- LowGlenmark Recalls Aprepitant Capsules Due to Missing Capsules in Blister Packs
FDA (Drugs) · 2018-12-26
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14